features interview with Kurt Zatloukal about the Instand-NGS4P project and the challenges of bringing NGS to patients 29.6.2020

Challenges of bringing NGS to patients

Article by 29 June 2020

Prof Kurt Zatloukal, Coordinator of the EU-funded Pre-Commercial Procurement project, Instand-NGS4P, talks to, a leading online publication in Europe focussing on vital issues impacting science, technology, engineering and maths.

Prof. Zatloukal highlights in this interview the challenges facing the scientific community with regard to regulatory requirements and the need to demonstrate the health economic benefit of NGS for routine healthcare and ultimately the patient.

Read the full article

Previous Story

Instand-NGS4P project presentation published on the CORDIS News site 24.6.2020

Next Story

Instand-NGS4P establishes liaison with ISO Technical Committee for Biotechnology 22.7.2020